ReviewItalian journal of pediatrics2026
Crossed cerebellar diaschisis in a COVID-19 patient with hemiconvulsion-hemiplegia syndrome: a case report and literature review.
Review in Italian journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundCrossed cerebellar diaschisis (CCD) is rare in patients with hemiconvulsion-hemiplegia syndrome (HHS). This report presents a novel and instructive case of CCD combined with HHS in a 7-month-old infant with coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C). MAIN BODY: A previously healthy 7-month-old male infant presented with high-grade fever, frequent left-sided seizures, and subsequent left-sided paralysis. Diagnosed with COVID-19 and MIS-C, he exhibited critical hyperinflammation and multi-organ dysfunction. Brain magnetic resonance imaging (MRI) was pivotal, revealing unilateral cytotoxic edema in the right cerebral hemisphere and restricted diffusion in the contralateral cerebellum, confirming the diagnoses of HHS and CCD. Despite management with anticonvulsants and immunomodulation, his condition deteriorated rapidly, leading to death within 45 h. The pathophysiology is proposed to center on the MIS-C-triggered cytokine storm, which likely creates a substrate for excitotoxic injury and diaschisis.
conclusionThis case represents, to our knowledge, the first documented fatal instance of CCD associated with HHS in a pediatric patient with acute COVID-19 and MIS-C. It underscores the potential for severe neurological complications in this population and broadens the recognized spectrum of neurovascular injuries linked to COVID-19. The early detection of CCD in such settings may serve as a critical radiological marker for a high-risk disease course.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.